MCKESSON WKN: 893953 ISIN: US58155Q1031 Kürzel: MCK Forum: Aktien Thema: Hauptdiskussion
536,46 USD
-1,27 %-6,91
30. Apr, 02:04:00 Uhr,
Nasdaq
Darüber diskutieren die Nutzer
Der User longisbetter hat aufgrund des Konjunkturpakets in McKesson investiert und ist mit der Bewertung zufrieden. Er berichtet, dass die Aktie gut läuft und er sie verkauft hat. Der User Solix hat keine Aussage getroffen. Der User Summer. 76 teilt verschiedene Neuigkeiten zu McKesson, darunter eine Erhöhung der Dividende, eine Akquisition von Rx Savings Solutions und eine Erhöhung der Prognose für das laufende Geschäftsjahr.
Kommentare 29
Summer.76,
7. Feb 22:12 Uhr
0
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
https://www.businesswire.com/news/home/20240207770220/en/
Summer.76,
01.11.2023 21:12 Uhr
0
https://www.businesswire.com/news/home/20231031995376/en/
McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
Summer.76,
24.07.2023 17:10 Uhr
0
https://www.benzinga.com/pressreleases/23/07/b33342907/mckesson-raises-quarterly-dividend-by-15-to-0-62-per-share
McKesson Raises Quarterly Dividend by 15% to $0.62 Per Share
Summer.76,
09.05.2023 6:10 Uhr
0
McKesson Corporation Reports Fiscal Fourth-Quarter and Full-year Results and Raises Long-Term Segment Growth Targets
https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2023/McKesson-Reports-Fiscal-2023-Fourth-Quarter-Full-Year-Results/
Summer.76,
20.03.2023 21:22 Uhr
0
https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2023/McKesson-Medical-Surgical-Government-Solutions-Awarded-Federal-Supply-Schedule-Contract/
Summer.76,
01.02.2023 22:17 Uhr
0
McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M
https://seekingalpha.com/news/3930812-mckesson-non-gaap-eps-of-6_90-beats-0_54-revenue-of-70_5b-misses-480m
• McKesson press release (NYSE:MCK): Q3 Non-GAAP EPS of $6.90 beats by $0.54.
• Revenue of $70.5B (+2.8% Y/Y) misses by $480M.
• ...
• Increased fiscal 2023 Adjusted Earnings per Diluted Share guidance range to $25.75 to $26.15, from the previous range of $24.45 to $24.95 vs. $24.80 consensus
Summer.76,
01.02.2023 22:11 Uhr
0
https://www.businesswire.com/news/home/20230131006173/en/McKesson-Corporation-Reports-Fiscal-2023-Third-Quarter-Results
Summer.76,
06.01.2023 18:02 Uhr
0
McKesson (NYSE:MCK) Price Target Increased to $420.00 by Analysts at Morgan Stanley
https://www.marketbeat.com/instant-alerts/nyse-mck-a-buy-or-sell-right-now-2023-01/
Summer.76,
01.11.2022 21:26 Uhr
0
https://seekingalpha.com/news/3899031-mckesson-non-gaap-eps-of-6_06-misses-0_03-revenue-of-70_2b-beats-120m
McKesson Non-GAAP EPS of $6.06 misses by $0.03, revenue of $70.2B beats by $120M
• McKesson press release (NYSE:MCK): Q2 Non-GAAP EPS of $6.06 misses by $0.03.
• Revenue of $70.2B (+5.4% Y/Y) beats by $120M.
• Fiscal 2023 Outlook: • Increased fiscal 2023 Adjusted Earnings per Diluted Share guidance range to $24.45 to $24.95, from the previous range of $23.95 to $24.65 from prior outlook of $23.95-$24.65 vs. $24.50 consensus
Summer.76,
01.11.2022 21:12 Uhr
0
McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance
https://www.businesswire.com/news/home/20221101005938/en/McKesson-Corporation-Reports-Fiscal-2023-Second-Quarter-Results-and-Raises-Full-Year-Guidance
Summer.76,
19.09.2022 15:13 Uhr
0
McKesson Signs Agreement to Acquire Rx Savings Solutions
https://www.businesswire.com/news/home/20220918005071/en/McKesson-Signs-Agreement-to-Acquire-Rx-Savings-Solutions
Acquisition aligns with McKesson’s strategic growth focus by connecting biopharma and payer services to patients
...
Ayt09,
03.08.2022 22:23 Uhr
1
https://seekingalpha.com/news/3866363-mckesson-non-gaap-eps-of-5_83-beats-0_53-revenue-of-67_2b-beats-2_38b?utm_source=mystocksportfolio.app&utm_medium=referral
Ayt09,
03.08.2022 22:21 Uhr
0
https://www.webullapp.com/news-detail/52219615?__app_cfg__=%7B%22supportTheme%22%3Atrue%2C%22sourcePage%22%3A%22StockNews%22%7D&tickerId=913323715&disSymbol=MCK&theme=1&color=2&hl=en&android_sdk_int=30&canary-version=&_v=1&sp=1&statusBarHeightV2=25
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | Nantkwest / Immunitybio -> IBRX | +22,31 % | |
2 | TESLA MOTORS Hauptdiskussion | +15,31 % | |
3 | PAYPAL Hauptdiskussion | +1,56 % | |
4 | Dolfines | ±0,00 % | |
5 | Trading- und Aktien-Chat | ||
6 | INFINEON Hauptdiskussion | +0,29 % | |
7 | FRANKLIN RESOURCES Hauptdiskussion | -6,42 % | |
8 | NESTE OIL Hauptdiskussion | -1,51 % | |
9 | Das neue Dax Prognose Forum | -0,28 % | |
10 | Aurora Cannabis Hauptdiskussion | -5,67 % | Alle Diskussionen |
Anzeige
Aktien
|
Thema | ||
---|---|---|---|
1 | Nantkwest / Immunitybio -> IBRX | +22,31 % | |
2 | TESLA MOTORS Hauptdiskussion | +15,31 % | |
3 | PAYPAL Hauptdiskussion | +1,56 % | |
4 | Dolfines | ±0,00 % | |
5 | INFINEON Hauptdiskussion | +0,29 % | |
6 | FRANKLIN RESOURCES Hauptdiskussion | -6,42 % | |
7 | NESTE OIL Hauptdiskussion | -1,51 % | |
8 | Aurora Cannabis Hauptdiskussion | -5,67 % | |
9 | NEL ASA Hauptdiskussion | +1,84 % | |
10 | NETCENTS TECHNOLOGY INC. Hauptdiskussion | +9.900,00 % | Alle Diskussionen |